Boston Scientific (BSX) Non Operating Income (2009 - 2026)

Boston Scientific has disclosed Non Operating Income across 18 years of filings, most recently posting $61.0 million for Q1 2026.

• Non Operating Income for Q1 2026 came in at $61.0 million, up 152.59% year-over-year; the trailing twelve-month figure through Mar 2026 was -$52.0 million (up 85.98% YoY), and the FY2025 annual result was -$228.0 million, up 28.97% from the prior year.
• Non Operating Income came in at $61.0 million for Q1 2026 at Boston Scientific, up from -$125.0 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $122.0 million in Q2 2025 to a low of -$412.0 million in Q4 2022.
• The 5-year median for Non Operating Income is -$83.0 million (2023), against an average of -$79.6 million.
• Across the five-year window, Non Operating Income sank 575.41% in 2022 and surged 222.0% in 2025, its largest moves.
• Boston Scientific's Non Operating Income stood at -$412.0 million in 2022, then soared by 80.83% to -$79.0 million in 2023, then slipped by 13.92% to -$90.0 million in 2024, then slumped by 38.89% to -$125.0 million in 2025, then surged by 148.8% to $61.0 million in 2026.
• The last three Non Operating Income figures came in at $61.0 million (Q1 2026), -$125.0 million (Q4 2025), and -$110.0 million (Q3 2025), per Business Quant data.